5 Oct 2026, 08:36
Meetings & Governance—
RACRACURA ONCOLOGY LTD
Announcement history available from 1 August 2025
Fromto
29 Sept 2026, 17:24
Director Interests—
23 Sept 2026, 08:39
Director Interests—
8 Sept 2026, 09:15
Company Administration—
4 Sept 2026, 09:57
Company Administration—
1 Sept 2026, 13:15
Securities Administration—
1 Sept 2026, 08:58
Company UpdateMS
25 Aug 2026, 17:22
Company Administration—
25 Aug 2026, 17:21
Company Administration—
25 Aug 2026, 17:21
Financial ResultsMS
29 July 2026, 09:12
Presentations—
29 July 2026, 09:04
Company UpdateMS
28 July 2026, 09:12
Quarterly ReportsMS
13 July 2026, 08:57
Securities Administration—
9 July 2026, 10:42
Company Update—
6 July 2026, 12:38
Presentations—
3 July 2026, 08:46
Company UpdateMS
2 July 2026, 08:29
Securities Administration—
25 June 2026, 08:55
Company UpdateMS
16 June 2026, 12:54
Company Administration—
16 June 2026, 12:36
Company UpdateMS
16 June 2026, 12:33
Securities Administration—
16 June 2026, 12:27
Securities Administration—
11 June 2026, 14:50
Securities Administration—
11 June 2026, 14:49
Securities Administration—
9 June 2026, 08:48
Director Interests—
4 June 2026, 12:02
Securities Administration—
4 June 2026, 11:57
Securities Administration—
4 June 2026, 08:52
Securities Administration—
4 June 2026, 08:50
Capital RaisingMS
1 June 2026, 15:40
Securities Administration—
29 May 2026, 14:50
Securities Administration—
28 May 2026, 16:43
Securities Administration—
28 May 2026, 16:43
Securities AdministrationMS
28 May 2026, 12:12
Director Interests—
28 May 2026, 12:07
Securities Administration—
26 May 2026, 13:21
Director Interests—
26 May 2026, 13:18
Securities Administration—
21 May 2026, 13:15
Director Interests—
21 May 2026, 13:12
Securities Administration—
21 May 2026, 09:34
Company Administration—
15 May 2026, 09:04
Company UpdateMS
14 May 2026, 12:56
Director Interests—
14 May 2026, 12:50
Securities Administration—
8 May 2026, 09:08
Company Administration—
7 May 2026, 12:10
Director Interests—
7 May 2026, 12:07
Securities Administration—
4 May 2026, 13:04
Securities Administration—
30 Apr 2026, 13:24
Securities Administration—
30 Apr 2026, 08:50
Quarterly ReportsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 08:36 | Date of AGM & Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 29 Sept 2026, 17:24 | Appendix 3Y - Dr Daniel Tillett | Director Interests | — | 02009 | |
| 23 Sept 2026, 08:39 | Appendix 3Y - Dr Daniel Tillett | Director Interests | — | 02009 | |
| 8 Sept 2026, 09:15 | RC220 MYC-silencing data to be presented FCS 26 conference | Company Administration | — | 12008 | |
| 4 Sept 2026, 09:57 | Racura Oncology Adelaide Investor Briefing | Company Administration | — | 12008 | |
| 1 Sept 2026, 13:15 | Notification regarding unquoted securities - RAC | Securities Administration | — | 06021 | |
| 1 Sept 2026, 08:58 | CPACS Trial Opens for RC220 Patient Enrolment in Korea | Company Update | MS | 11001 | |
| 25 Aug 2026, 17:22 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 25 Aug 2026, 17:21 | Appendix 4G | Company Administration | — | 03025 | |
| 25 Aug 2026, 17:21 | Appendix 4E & Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 29 July 2026, 09:12 | Racure Oncology Techknow Invest Presentation | Presentations | — | 03026 | |
| 29 July 2026, 09:04 | First HARNESS-1 Patient Safely Treated with RC220 | Company Update | MS | 11001 | |
| 28 July 2026, 09:12 | June 2026 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 13 July 2026, 08:57 | Notification of cessation of securities - RAC | Securities Administration | — | 06027 | |
| 9 July 2026, 10:42 | Racura to Present CPACS Data at GCOS 2026 | Company Update | — | 11001 | |
| 6 July 2026, 12:38 | Racura Oncology New Zealand Investor Events | Presentations | — | 14014 | |
| 3 July 2026, 08:46 | Bellberry Ethics Approval Activates New HARNESS Trial Sites | Company Update | MS | 11001 | |
| 2 July 2026, 08:29 | Notification of cessation of securities - RAC | Securities Administration | — | 06027 | |
| 25 June 2026, 08:55 | Racura Treats First Patient in HARNESS-1 Lung Cancer Trial | Company Update | MS | 11001 | |
| 16 June 2026, 12:54 | Racura Oncology Investor Briefings Perth & Auckland | Company Administration | — | 12008 | |
| 16 June 2026, 12:36 | Racura raised $34.3m to Advance Three Oncology Trials | Company Update | MS | 11001 | |
| 16 June 2026, 12:33 | Cleansing Notice | Securities Administration | — | 06018 | |
| 16 June 2026, 12:27 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 11 June 2026, 14:50 | Cleansing Notice | Securities Administration | — | 06018 | |
| 11 June 2026, 14:49 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 9 June 2026, 08:48 | Appendix 3Y-Dr Serge Scrofani | Director Interests | — | 02009 | |
| 4 June 2026, 12:02 | Racura Options Raised $24.4m | Securities Administration | — | 06009 | |
| 4 June 2026, 11:57 | Notification of cessation of securities - RAC | Securities Administration | — | 06027 | |
| 4 June 2026, 08:52 | Proposed issue of securities - RAC | Securities Administration | — | 06013 | |
| 4 June 2026, 08:50 | Emerging Companies Specialist Invests in Racura | Capital Raising | MS | 06003 | |
| 1 June 2026, 15:40 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 29 May 2026, 14:50 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 28 May 2026, 16:43 | Proposed issue of securities - RAC | Securities Administration | — | 06013 | |
| 28 May 2026, 16:43 | Racura Enters Underwriting Agreement for Options | Securities Administration | MS | 06009 | |
| 28 May 2026, 12:12 | Appendix 3Y - Dr Daniel Tillett | Director Interests | — | 02009 | |
| 28 May 2026, 12:07 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 26 May 2026, 13:21 | Appendix 3Y - Dr Daniel Tillett | Director Interests | — | 02009 | |
| 26 May 2026, 13:18 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 21 May 2026, 13:15 | Appendix 3Y - Dr Daniel Tillett | Director Interests | — | 02009 | |
| 21 May 2026, 13:12 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 21 May 2026, 09:34 | Racura Oncology Final Option Expiry Reminder | Company Administration | — | 06009, 12008 | |
| 15 May 2026, 09:04 | CPACS Trial Cleared to Escalate to Next RC220 Dose Level | Company Update | MS | 11001 | |
| 14 May 2026, 12:56 | Appendix 3Y - Dr Daniel Tillett | Director Interests | — | 02009 | |
| 14 May 2026, 12:50 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 8 May 2026, 09:08 | Racura Oncology Options Expiry Reminder | Company Administration | — | 06009, 12008 | |
| 7 May 2026, 12:10 | Appendix 3Y - Dr Daniel Tillett | Director Interests | — | 02009 | |
| 7 May 2026, 12:07 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 4 May 2026, 13:04 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 30 Apr 2026, 13:24 | Application for quotation of securities - RAC | Securities Administration | — | 06020 | |
| 30 Apr 2026, 08:50 | March 2026 Quarterly Activity Report and Appendix 4C | Quarterly Reports | MS | 03002, 19003, 19008 |
1–50 of 152
1 / 4